These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 6471944

  • 1. [Early morning dystonia: a complication of levodopa therapy in Parkinson disease. Presentation of 4 cases].
    Molina Arjona JA, Arnal García C, Calandre Hoenigsfeld L, Bermejo Pareja F.
    Med Clin (Barc); 1984 Jun 09; 83(2):47-9. PubMed ID: 6471944
    [No Abstract] [Full Text] [Related]

  • 2. The pharmacology of foot dystonia in parkinsonism.
    Poewe WH, Lees AJ.
    Clin Neuropharmacol; 1987 Jun 09; 10(1):47-56. PubMed ID: 3545460
    [No Abstract] [Full Text] [Related]

  • 3. Complex dystonia of Parkinson's disease: clinical features and relation to plasma levodopa profile.
    McHale DM, Sage JI, Sonsalla PK, Vitagliano D.
    Clin Neuropharmacol; 1990 Apr 09; 13(2):164-70. PubMed ID: 2328507
    [Abstract] [Full Text] [Related]

  • 4. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
    Pacchetti C, Albani G, Martignoni E, Godi L, Alfonsi E, Nappi G.
    Mov Disord; 1995 May 09; 10(3):333-6. PubMed ID: 7651452
    [Abstract] [Full Text] [Related]

  • 5. Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
    Klawans HL, Paleologos N.
    Clin Neuropharmacol; 1986 May 09; 9(3):298-302. PubMed ID: 3719575
    [Abstract] [Full Text] [Related]

  • 6. Foot dystonia in Parkinson's disease: clinical phenomenology and neuropharmacology.
    Poewe W, Lees AJ, Steiger D, Stern GM.
    Adv Neurol; 1987 May 09; 45():357-60. PubMed ID: 3825711
    [No Abstract] [Full Text] [Related]

  • 7. Parkinsonism following dystonia in three patients.
    Katchen M, Duvoisin RC.
    Mov Disord; 1986 May 09; 1(2):151-7. PubMed ID: 3504239
    [Abstract] [Full Text] [Related]

  • 8. Forms of dystonia in patients with Parkinson's disease.
    Kidron D, Melamed E.
    Neurology; 1987 Jun 09; 37(6):1009-11. PubMed ID: 3587617
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A family with hereditary juvenile dystonia-parkinsonism.
    Ishikawa A, Miyatake T.
    Mov Disord; 1995 Jul 09; 10(4):482-8. PubMed ID: 7565830
    [Abstract] [Full Text] [Related]

  • 11. [Dystonia preceding dopa-responsive parkinsonism--heterogeneous clinical features].
    Miwa H, Mizuno Y.
    No To Shinkei; 1996 Feb 09; 48(2):149-54. PubMed ID: 8865694
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dopa-responsive dystonia: a widening spectrum.
    Gordon N.
    Dev Med Child Neurol; 1996 Jun 09; 38(6):554-9. PubMed ID: 8647336
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [L-dopa and bromocriptine in Parkinson disease. Early combination therapy has better effect].
    Olsson JE, Duchek M, Ekberg R, Fehling C, Johansson F, Johnels B, Lindvall B, Nordin G, Sidén A, Steg G.
    Lakartidningen; 1993 Apr 21; 90(16):1545-8. PubMed ID: 8483351
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.